178 related articles for article (PubMed ID: 14720275)
1. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs.
Leick-Maldonado EA; Kay FU; Leonhardt MC; Kasahara DI; Prado CM; Fernandes FT; Martins MA; Tibério IF
Clin Exp Allergy; 2004 Jan; 34(1):145-52. PubMed ID: 14720275
[TBL] [Abstract][Full Text] [Related]
2. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Henderson WR; Chiang GK; Tien YT; Chi EY
Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
[TBL] [Abstract][Full Text] [Related]
3. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
4. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
[TBL] [Abstract][Full Text] [Related]
5. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
6. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
7. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
8. Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.
Sade K; Schwartz I; Schwartz D; Wolman Y; Chernichovski T; Fireman E; Iaina A; Kivity S
Clin Exp Allergy; 2003 Dec; 33(12):1741-6. PubMed ID: 14656364
[TBL] [Abstract][Full Text] [Related]
9. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
11. Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation.
Abdel Kawy HS
COPD; 2016 Aug; 13(4):455-63. PubMed ID: 26751767
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
Stelmach I; Jerzynska J; Kuna P
Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
[TBL] [Abstract][Full Text] [Related]
13. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
14. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
[TBL] [Abstract][Full Text] [Related]
16. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
18. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
Pizzichini E; Leff JA; Reiss TF; Hendeles L; Boulet LP; Wei LX; Efthimiadis AE; Zhang J; Hargreave FE
Eur Respir J; 1999 Jul; 14(1):12-8. PubMed ID: 10489822
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
20. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
